Yahoo · Nov 10, 2026
Opus Genetics, Inc. (IRD) Reports Q3 Loss, Lags Revenue Estimates
Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of -28.57% and -43.80%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?


